Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature

E-ISSN： 2212-3970|13|4|422-427

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.13, Iss.4, 2018-11, pp. : 422-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of Selected Patents for Cancer Therapy Targeting Tumor Angiogenesis

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

Tumoral Angiogenesis: Review of the Literature

By Shahi Parham Khosravi Pineda Israel Fernandez

Cancer Investigation, Vol. 26, Iss. 1, 2007-12 ,pp. : 104-108

Informa Healthcare

Access to resources Recommend Favorite

EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis

By Crea Francesco

Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. : 753-761

Springer Publishing Company

Access to resources Recommend Favorite

Combating angiogenesis early: potential of targeting tumor-recruited neutrophils in cancer therapy

By Quigley James P Deryugina Elena I

Future Oncology, Vol. 8, Iss. 1, 2012-01 ,pp. : 5-8

Future Medicine

Access to resources Recommend Favorite

Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 1, 2016-02 ,pp. : 2-66

Bentham Science Publishers

Access to resources Recommend Favorite